Value of Apo B and ratio of Apo AⅠ/Apo B in differential diagnosis between familial hypercholesterolemia and familial combined hyperlipidemia
YAN Li1, FU Xiao-yan1, ZHOU Shan-shan2, LIU Wei-juan3, HE Jin-xiang1,4, HE Jin-chun1,5
1.First Clinical School of Lanzhou University, Lanzhou 730000, China; 2.Department of Laboratory Medicine, Childrens Hospital of Hebei Province, Shijiazhuang 050000, China; 3.Department of Laboratory Medicine, Peoples Hospital of Linfen, Linfen 041000, China; 4.Department of Radiotherapy, First Hospital of Lanzhou University, Lanzhou 730000, China; 5.Department of Laboratory Medicine, First Hospital of Lanzhou University, Lanzhou 730000, China
Online:2016-05-28
Published:2016-05-26
Supported by:
National Science and Technology Major Project of the Ministry of Science and Technology of China during the“10th Five-Year Plan”,2002DA711A028-17;Science and Technology Foundation Construction of Ministry of Education,505015; Natural Science Foundation of Gansu Province,1308RJZA218,1302FKDA034
YAN Li, FU Xiao-yan, ZHOU Shan-shan, LIU Wei-juan, HE Jin-xiang, HE Jin-chun. Value of Apo B and ratio of Apo AⅠ/Apo B in differential diagnosis between familial hypercholesterolemia and familial combined hyperlipidemia[J]. , doi: 10.3969/j.issn.1674-8115.2016.05.011.